Carvedilol-Mepha 3.125

Carvedilol-Mepha 3.125 is a medicine authorised by Swissmedic under authorisation number 57652. The authorisation holder is Mepha Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 31 October 2006 and the authorisation is valid without a time limit. ATC code C07AG02 places the medicine in the group Beta blocking agents.

  • Dispensing category B
  • Authorisation number 57652
  • ATC C07AG02
  • Synthetic medicines
Authorisation data
Authorisation number57652
NameCarvedilol-Mepha 3.125
Full nameCarvedilol-Mepha 3.125 , Tabletten
Authorisation holderMepha Pharma AG
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codeC07AG02
First authorisation31 October 2006
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Carvedilol-Mepha 3.125 , TablettenB31 October 2006
2Carvedilol-Mepha 6.25, TablettenB31 October 2006
3Carvedilol-Mepha 12.5, TablettenB31 October 2006
4Carvedilol-Mepha 25, TablettenB31 October 2006

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
130Tablette(n)C07AG0202.07.1.B
330Tablette(n)C07AG0202.07.1.B
530Tablette(n)C07AG0202.07.1.B
7100Tablette(n)C07AG0202.07.1.B
930Tablette(n)C07AG0202.07.1.B
11100Tablette(n)C07AG0202.07.1.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Carvedilol-Mepha 3.125 authorised in Switzerland?

Yes. Carvedilol-Mepha 3.125 is authorised by Swissmedic under authorisation number 57652, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Carvedilol-Mepha 3.125 have?

Carvedilol-Mepha 3.125 is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Carvedilol-Mepha 3.125?

The authorisation holder is Mepha Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com